CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company
PGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGXTSX Venture
CZO
Change
Volume
Day Range
52 Week Range
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Ceapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Aeterna Zentaris and Ceapro Complete Merger Transaction
Jun 3, 2024 | Read More
Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update
May 29, 2024 | Read More
Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
Apr 29, 2024 | Read More
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
Mar 28, 2024 | Read More